Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
November 08, 2025 17:13 ET Â | Source: Intellia Therapeutics, Inc. Deep, stable…
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc.…
The 5th World Health Forum Highlights Climate Change as a Defining Public Health Challenge
BEIJING, Nov. 4, 2025 /PRNewswire/ -- The 5th World Health Forum convened…
Healthcare Holding Schweiz Acquires a Stake in QUNIQUE
Healthcare Holding Schweiz AG, a leading provider of medical technology services and…
CGTN: How China’s high-standard opening up fuels high-quality development
BEIJING, Nov. 9, 2025 /PRNewswire/ -- Following President Xi Jinping's visits to…
Agora and Akool Launch Conversational AI + Streaming Avatar Collaboration
Agora and Akool integrate real-time conversational AI with lifelike streaming avatars to…
TACC Positions India as a Global Hub for Advanced Energy Materials
Leveraging HEG's global legacy, the company aims to build a cost-competitive and…
The Battery Show Asia to Spark Innovation Again in March 2026
The Battery Show Asia (TBSA) 2026 is set to make a grand…
CII launches National Circular Economy Framework Edition 3 at the 10th International Conference on Waste to Worth Technologies in New Delhi
NEW DELHI, Nov. 7, 2025 /PRNewswire/ -- The Confederation of Indian Industry…
Put Children’s Education at the Heart of Discussions at COP30 in Brazil
Education Cannot Wait and Geneva Global Hub for Education in Emergencies Call…